Epigenetic drugs show promise as antivirals

Epigenetic drugs show promise as antivirals

Epigenetic Drugs Show Promise As Antivirals

Some epigenetic pharmaceuticals have the potential to be used as broad spectrum antivirals, according to a new study. The study demonstrated that histone methyltransferases EZH2/1 inhibitors, which are being used in cancer clinical trials, have activity against a variety of viruses, including herpes simplex virus (HSV).

Epigenetic Drugs Show Promise As Antivirals
Epigenetic Drugs Show Promise As Antivirals
Epigenetic Drugs Show Promise As Antivirals
Epigenetic Drugs Show Promise As Antivirals
Epigenetic Drugs Show Promise As Antivirals

Epigenetic Drugs Show Promise As Antivirals

8
Like
Save

Comments

Comments are disabled for this post.